These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21837737)

  • 1. Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection.
    Kneteman NM; Asthana S; Lewis J; Dibben C; Douglas D; Nourbakhsh M; Tyrrell LJ; Lund G
    Liver Transpl; 2012 Jan; 18(1):38-44. PubMed ID: 21837737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha.
    Pan Q; Metselaar HJ; de Ruiter P; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Liver Transpl; 2010 Apr; 16(4):520-6. PubMed ID: 20373462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo.
    Inoue K; Umehara T; Ruegg UT; Yasui F; Watanabe T; Yasuda H; Dumont JM; Scalfaro P; Yoshiba M; Kohara M
    Hepatology; 2007 Apr; 45(4):921-8. PubMed ID: 17393519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype-4 recurrence post-liver transplantation: A prospective cohort trial.
    El-Hamamsy M; Montasser IF; Mansy AE; Nabet DE; El-Meteini M
    J Clin Pharm Ther; 2019 Jun; 44(3):447-453. PubMed ID: 30714175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus viral kinetics during α-2a or α-2b pegylated interferon plus ribavirin therapy in liver transplant recipients with different immunosuppression regimes.
    Berenguer M; Ortíz-Cantó C; Abellán JJ; Aguilera V; Rubín A; Prieto M; López-Labrador FX
    J Clin Virol; 2012 Mar; 53(3):231-8. PubMed ID: 22222052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
    Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
    Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application.
    Kneteman NM; Weiner AJ; O'Connell J; Collett M; Gao T; Aukerman L; Kovelsky R; Ni ZJ; Zhu Q; Hashash A; Kline J; Hsi B; Schiller D; Douglas D; Tyrrell DL; Mercer DF
    Hepatology; 2006 Jun; 43(6):1346-53. PubMed ID: 16729319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
    Nanmoku K; Imaizumi R; Tojimbara T; Nakajima I; Fuchinoue S; Sakamoto N; Watanabe M; Teraoka S
    Transplant Proc; 2008 Sep; 40(7):2382-5. PubMed ID: 18790241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.
    Reiberger T; Rasoul-Rockenschaub S; Rieger A; Ferenci P; Gangl A; Peck-Radosavljevic M
    Eur J Clin Invest; 2008 Jun; 38(6):421-9. PubMed ID: 18489402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis.
    Rabie R; Mumtaz K; Renner EL
    Liver Transpl; 2013 Jan; 19(1):36-48. PubMed ID: 22821730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
    Berenguer M; Aguilera V; San Juan F; Benlloch S; Rubin A; López-Andujar R; Moya A; Pareja E; Montalva E; Yago M; de Juan M; Mir J; Prieto M
    Transplantation; 2010 Dec; 90(11):1204-9. PubMed ID: 21068701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.
    Werner CR; Egetemeyr DP; Lauer UM; Nadalin S; Königsrainer A; Malek NP; Berg CP
    Liver Transpl; 2012 Dec; 18(12):1464-70. PubMed ID: 22941516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
    Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
    Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
    Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
    J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
    Vispo E; Barreiro P; Rodriguez-Nóvoa S; Morello J; Labarga P; Martín-Carbonero L; Maida I; García-Gascó P; Soriano V
    Antivir Ther; 2008; 13(4):511-7. PubMed ID: 18672529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of mice and men, calcineurin inhibitors and hepatitis C.
    Rutebemberwa A; Rosen HR
    Liver Transpl; 2012 Jan; 18(1):1-4. PubMed ID: 22034173
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained virological response to antiviral therapy in a randomized trial of cyclosporine versus tacrolimus in liver transplant patients with recurrent hepatitis C infection.
    Duvoux C; Villamil F; Renner EL; Grazi GL; Firpi RJ; Pageaux G; Mulhaupt B; Schirm F; Rauer B; Bernhardt P; Levy G
    Ann Transplant; 2015 Jan; 20():25-35. PubMed ID: 25588713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.
    Kneteman NM; Howe AY; Gao T; Lewis J; Pevear D; Lund G; Douglas D; Mercer DF; Tyrrell DL; Immermann F; Chaudhary I; Speth J; Villano SA; O'Connell J; Collett M
    Hepatology; 2009 Mar; 49(3):745-52. PubMed ID: 19072827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
    Watashi K; Metselaar HJ; van der Laan LJ
    Liver Transpl; 2008 Mar; 14(3):265-7. PubMed ID: 18306373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.